Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals.

Yoanna S PumpalovaAlexandra M RogersSarah Xinhui Tan Candice-Lee HerbstPaul RuffAlfred I Neugut Chin Hur

Published in: JCO global oncology (2022)

In ZA public hospitals, CAPOX for 3 months is the cost-effective adjuvant treatment for stage III colon cancer. The optimal strategy in other settings may change according to local WTP thresholds. Decision analytic tools can play a vital role in selecting cost-effective cancer therapeutics in resource-constrained settings.

Keyphrases

healthcare
mental health
papillary thyroid
early stage
small molecule
squamous cell
emergency department
replacement therapy